- Home
- KPLT vs AEON Comparison
KPLT vs AEON Comparison
Compare KPLT & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- AEON
- Stock Information
- Founded
- KPLT 2012
- AEON N/A
- Country
- KPLT United States
- AEON United States
- Employees
- KPLT N/A
- AEON N/A
- Industry
- KPLT Diversified Commercial Services
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- KPLT Consumer Discretionary
- AEON Health Care
- Exchange
- KPLT Nasdaq
- AEON Nasdaq
- Market Cap
- KPLT 33.2M
- AEON 36.4M
- IPO Year
- KPLT N/A
- AEON N/A
- Fundamental
- Price
- KPLT $5.92
- AEON $0.63
- Analyst Decision
- KPLT Hold
- AEON Strong Buy
- Analyst Count
- KPLT 2
- AEON 1
- Target Price
- KPLT $12.00
- AEON $5.00
- AVG Volume (30 Days)
- KPLT 24.0K
- AEON 296.7K
- Earning Date
- KPLT 11-06-2024
- AEON 11-13-2024
- Dividend Yield
- KPLT N/A
- AEON N/A
- EPS Growth
- KPLT N/A
- AEON N/A
- EPS
- KPLT N/A
- AEON 0.34
- Revenue
- KPLT $241,789,000.00
- AEON N/A
- Revenue This Year
- KPLT $12.92
- AEON N/A
- Revenue Next Year
- KPLT $6.30
- AEON N/A
- P/E Ratio
- KPLT N/A
- AEON $1.88
- Revenue Growth
- KPLT 14.99
- AEON N/A
- 52 Week Low
- KPLT $5.79
- AEON $0.52
- 52 Week High
- KPLT $23.54
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- KPLT 36.71
- AEON 45.65
- Support Level
- KPLT $6.09
- AEON $0.61
- Resistance Level
- KPLT $6.91
- AEON $0.68
- Average True Range (ATR)
- KPLT 0.48
- AEON 0.12
- MACD
- KPLT -0.01
- AEON 0.01
- Stochastic Oscillator
- KPLT 1.23
- AEON 22.02
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.